Search

Search Constraints

You searched for: Author/Creator Sperinde, Jeff

Search Results

1. Correlation Between Quantitative HER‐2 Protein Expression and Risk for Brain Metastases in HER‐2+ Advanced Breast Cancer Patients Receiving Trastuzumab‐Containing Therapy. (6th May 2013)

2. Potential biomarkers of long‐term benefit from single‐agent trastuzumab or lapatinib in HER2‐positive metastatic breast cancer. Issue 1 (13th September 2013)

3. Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases. Issue 9 (13th February 2015)

4. Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival. Issue 1 (December 2015)